| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |